Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Laboratory of Cell Genetics and Developmental Biology, Shaanxi Normal University College of Life Sciences, Xi'an 710062, China.
Cells. 2021 Jan 11;10(1):122. doi: 10.3390/cells10010122.
Under natural conditions, injured cells can be repaired rapidly through inherent biological processes. However, in the case of diabetes, cardiovascular disease, muscular dystrophy, and other degenerative conditions, the natural repair process is impaired. Repair of injury to the cell membrane is an important aspect of physiology. Inadequate membrane repair function is implicated in the pathophysiology of many human disorders. Recent studies show that Mitsugumin 53 (MG53), a TRIM family protein, plays a key role in repairing cell membrane damage and facilitating tissue regeneration. Clarifying the role of MG53 and its molecular mechanism are important for the application of MG53 in regenerative medicine. In this review, we analyze current research dissecting MG53's function in cell membrane repair and tissue regeneration, and highlight the development of recombinant human MG53 protein as a potential therapeutic agent to repair multiple-organ injuries.
在自然条件下,受损细胞可以通过固有生物过程迅速修复。然而,在糖尿病、心血管疾病、肌肉营养不良症和其他退行性疾病的情况下,自然修复过程受损。细胞膜损伤的修复是生理学的一个重要方面。膜修复功能不足与许多人类疾病的病理生理学有关。最近的研究表明,泛素蛋白 53(MG53),一种 TRIM 家族蛋白,在修复细胞膜损伤和促进组织再生中发挥关键作用。阐明 MG53 的作用及其分子机制对于将 MG53 应用于再生医学具有重要意义。在这篇综述中,我们分析了当前研究中关于 MG53 在细胞膜修复和组织再生中的功能,强调了重组人 MG53 蛋白作为修复多器官损伤的潜在治疗剂的发展。